According to information from a new study, AF is linked to the lesions in the brain that cause silent cerebral ischemic strokes as well as symptomatic strokes. This study was published online in the Journal of the American College of Cardiology.
The study was conducted by Dr. Fiorenzo Gaita, MD, of the University of Turin, Italy, and colleagues. What they found was that the arrhythmia increased the patient’s risks of having a silent stroke by 7.2 times. The study also found that even while the lesions didn’t appear completely benign for the patients that had no prior history of stroke, the group’s overall cognitive performance was much worse in those with persistent or paroxysmal AF.
These results confirm a whole new way that AF can cause damage to the brain, said Dr. Steven Shea, MD, and Marco Di Tullio, MD, both of Columbia University Medical Center in New York City.
“The most important question (now) is whether prophylactic antithrombotic treatment may be able to reduce the incidence of silent brain lesions as it has been proven to do for clinical strokes,” they wrote in an accompanying editorial.
Stroke risks are always higher in patients with all forms of AF. It is for this reason that many patients are treated with anticoagulant medications like Multaq, which are used to help prevent strokes. However, Multaq, like all other prescription medications, has been proven to be dangerous. Multaq is made by Sanofi-Aventis and has been linked to serious side effects including a worsening of the heart condition, liver failure and lung toxicity. It is for this reason that the FDA has recommended that doctors only prescribe Multaq if all other medications fail to work.
If you or a loved one has suffered from liver failure or a worsening heart condition after being treated with Multaq, contact the attorneys at Greg Jones today for a free consultation. I am experienced at fighting Multaq lawsuits and may be able to help you recover money for your injuries.